Meta-Analysis Refutes Link Between Erectile Dysfunction Drugs and Melanoma

Meta-Analysis Refutes Link Between Erectile Dysfunction Drugs and Melanoma

Drugs that treat erectile dysfunction (ED), like Viagra (sildenafil), do not increase the risk of developing a kind of deadly skin cancer, according to a large meta-analysis that looked at more than 866,000 men that had taken the medications.

The report, published in the Journal of the National Cancer Institute, is significant in that it came to a different conclusion than a 2014 JAMA Internal Medicine study that did find a link between sildenafil and a higher melanoma risk. The publication of that study prompted the FDA last year to put Viagra and other PDE5 inhibitors such as Cialis (tadalafil) and Levitra (vardenafil) on a watch list of drugs with potential safety issues.

In the new meta-analysis that examined 5 large clinical trials of men that took a PDE5 inhibitor and melanoma risk, researchers did find that men who took an ED drug had an 11% higher risk of developing melanoma. But they also found the men who took large amounts of ED drugs had no significant increase in melanoma risk, while men with little exposure to them had an elevated risk.

As to why this is the case, researchers attribute the increased risk in some ED users to what is known as “detection bias.” This means that some of the men who took PDE5 inhibitors are more health conscious and more likely to see their physician, and therefore more likely to get diagnosed with melanoma.

“Overall, Viagra and other PDE5 inhibitors are safe medications as long as men are not taking nitrates, which carry a risk of reducing blood pressure,” lead author Stacy Loeb, MD, a urologist at NYU Langone Medical Center, said in a statement. “Physicians and patients should not be concerned about taking these medications on account of worry about melanoma.”


Jonathan Block

Jonathan Block

Jonathan Block is a freelance writer and former MedShadow content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including BioCentury, The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.


Did you find this article helpful?


Latest News

Synthetic Red Blood Cells, NOAC’s for Atrial Fibrillation, Surgery to Ease Sciatica Pain

Synthetic Red Blood Cells, NOAC’s for Atrial Fibrillation, Surgery to Ease Sciatica Pain

Researchers have managed to create artificial red blood cells that can transport medication. Compared to the popular anticoagulant Warfarin, NOAC’s may be superior for treating atrial fibrillation patients with prior intracranial hemorrhage. Also, surgery may be the preferred choice for reducing leg pain in patients with sciatica.  Synthetic Red Blood…

FDA Recalls Metformin and NP Thyroid

FDA Recalls Metformin and NP Thyroid

The FDA has issued a recall of two drugs–NP Thyroid and Metformin–after testing revealed that they weren’t up to code. Read more below, and if you’re taking either medication, please be sure to contact your doctor for how to continue treatment responsibly.  NP Thyroid Recalled Thirteen lots of NP Thyroid,…

  • Advertisement